Details of the Drug

General Information of Drug (ID: DM3SPY9)

• Drug Name: BTI-410

Indication

Disease Entry	ICD 11	Status	REF
Type-1 diabetes	5A10	Phase 1	[1]
Type-2 diabetes	5A11	Phase 1	[1]

• Drug Type: Peptide
• Cross-matching ID: TTD ID: D1B2US
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of Boston Therapeutics.